{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-026195","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2025-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.220965+00:00","generated_at":"2026-05-16T14:34:47.329515+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Palisade Bio shareholders approve increase in authorized shares to 300M and warrant issuance of up to 8.64M shares","bullets":["Authorized common stock increased from 280M to 300M shares via certificate of amendment filed Dec. 3, 2025.","Stockholders approved issuance of up to 8,637,810 common shares underlying warrants under July 23, 2025 inducement agreement.","Proposal passed with ~126.3M votes for; quorum of 85.53% of outstanding shares (148.96M) represented.","Warrant exercise required under Nasdaq Listing Rule 5635 because shares exceed 20% of pre-issuance outstanding.","Adjournment proposal also approved to allow further solicitation if needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-026195","json":"https://secwatch.observer/filing/0001493152-25-026195.json","markdown":"https://secwatch.observer/filing/0001493152-25-026195.md","text":"https://secwatch.observer/filing/0001493152-25-026195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225026195/0001493152-25-026195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225026195/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:34:47.329515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6ffb8e3f1b5052d4eb1329836a73ff2432e908c8","claim":"PALISADE BIO, INC.: Increased authorized shares of common stock from 280,000,000 to 300,000,000 (effective 2025-12-03).","evidence_excerpt":"On December 3, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the \"Amendment\") with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 280,000,000 shares to 300,000,000 shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225026195/0001493152-25-026195-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-12-03"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}